- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT00542737
Evaluating a Web-Based Ventilator Management Educational Program for Clinicians (The Lung Injury Knowledge Network [LINK] Study) (LINK)
Improving Ventilator Management and Preventing Injury to Patients With Acute Respiratory Failure
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Detailní popis
ALI/ARDS is a life-threatening condition that involves inflammation of the lungs and fluid accumulation in the air sacs, leading to low blood oxygen levels and respiratory failure. Common causes include pneumonia, septic shock, and lung trauma, and most patients require immediate care in an ICU. The main form of treatment for ALI/ARDS is the delivery of oxygen and a continuous level of pressure to the damaged lungs through mechanical ventilation. Each year, 74,500 people die due to ALI/ARDS and 22% of these deaths could be prevented with the use of LPV. LPV is a mechanical ventilation technique in which lower volumes of oxygen are administered. The purpose of this study is to implement and evaluate a Web-based educational program that will provide educational and instructional resources about ALI/ARDS and LPV to ICU clinicians, including physicians, nurses, and respiratory therapists.
Hospitals participating in this study will be randomly assigned to access the Web site at either the beginning of the study period or a later time. Participating clinicians at each hospital will access the Web site as often as necessary for a 6-month period. The Web site will contain background and educational information on ALI/ARDS and LPV, including how to recognize ALI/ARDS and how to implement LPV in patients. Scholarly articles and other materials, including a chart to help clinicians determine appropriate ventilator settings for each patient, will be available to download. Clinicians will also be able to email questions to critical care experts. At the end of the 6-month study period, study staff will compare the number of patients receiving LPV to the number of patients who received LPV prior to the start of the study.
Typ studie
Zápis (Očekávaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
Ontario
-
Toronto, Ontario, Kanada, M4N3M5
- University of Toronto, Sunnybrook Health Sciences
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria for Hospitals:
- Between 10 and 20 ICU beds with 5 to 10 ALI/ARDS patients cared for each month
- Provide critical care services
- Keep electronic medical records on ICU patients
- ICU staff must have access to computers with Intranet or Internet
Inclusion Criteria for Clinicians:
- Provide care for mechanically ventilated patients in ICUs
- Willing to participate by viewing Web site
Exclusion Criteria for Hospitals:
- Cardiac, cardiothoracic, neurosurgical, neonatal, or pediatric ICUs
- Residents and fellows must provide care to majority of critically ill patients
- Fewer than 5 to 10 ALI/ARDS patients cared for each month
Studijní plán
Jak je studie koncipována?
Detaily designu
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Aktivní komparátor: Early Intervention Group
|
Participating clinicians at each hospital will access the Web site as often as necessary for a 6-month period.
The Web site will contain background and educational information on ALI/ARDS and LPV, including how to recognize ALI/ARDS and how to implement LPV in patients.
Scholarly articles and other materials, including a chart to help clinicians determine appropriate ventilator settings for each patient, will be available to download.
Clinicians will also be able to email questions to critical care experts.
|
|
Aktivní komparátor: Delayed Intervention Group
|
Participating clinicians at each hospital will access the Web site as often as necessary for a 6-month period.
The Web site will contain background and educational information on ALI/ARDS and LPV, including how to recognize ALI/ARDS and how to implement LPV in patients.
Scholarly articles and other materials, including a chart to help clinicians determine appropriate ventilator settings for each patient, will be available to download.
Clinicians will also be able to email questions to critical care experts.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Časové okno |
|---|---|
|
Percentage of eligible patients with ALI/ARDS who are receiving LPV
Časové okno: Measured at Month 6
|
Measured at Month 6
|
Spolupracovníci a vyšetřovatelé
Spolupracovníci
Vyšetřovatelé
- Vrchní vyšetřovatel: Gordon D. Rubenfeld, MD, University of Toronto, Sunnybrook Health Sciences
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Primární dokončení (Očekávaný)
Dokončení studie (Očekávaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Odhad)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- 518
- R01HL067939 (Grant/smlouva NIH USA)
- GC1# A19846
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .